Biosimulation Market is Growing at An Impressive CAGR

Date: 2015-12-01

Biosimulation market is growing at an impressive CAGR from 2015-2021. With increasing use of personalized medicine and continuous research in the field the Biosimulation market is also growing at a faster rate, some of the big players of the field are Certara, Biovia, Dassault Systèmes inhibox etc. 

There are lot of factors driving the market such as advent of improved simulation and modeling tools as a result of continuous research and development in the field, also the increasing integration of the fields with other fields such as pharmaceutical and biotechnological is acting as a growth factor for the industry. With every passing day, number of aging people are increasing and also, increase in chronic diseases can be seen. These factors act as very strong market driver. Due to the lucrative market opportunities, other companies are also trying to enter this market. Regarding this, many collaborations and partnership among pharmaceutical players is seen. 

On the other hand, Asia-Pacific is projected to be a fast growing market, due to growing population and increase in number people investing in healthcare
 Companies profile include
1.  Certara USA, Inc.
2. Rhenovia Pharma Ltd. 
3. Physiomics PLC 
4. Genedata Ag 
5. Entelos Holding Corporation
6. Chemical Computing Group, Inc.
7. Advanced Chemistry Development, Inc. 
8.  Schrödinger Inc. 
9. Dassault Systèmes SA 
10. Simulation Plus Inc. 
11. Biovia (Formerly Accelrys) 
12. In silico biosciences
13. Inhibox 
14. Leadinvent Technologies
15. Leadscope
16. Nimbus therapeutics
17. Open eye Scientific software
18. Physiomics Plc.
19. Rhenovia Pharma
20. Genedata
This Occams Research Report covers
1. Historical data
2.Revenue forecasts, growth rates and CAGR up to 2021
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample